Shendi University Repository

Extended-spectrum Beta-lactamase- Producing Escherichia coli and Klebsiella pneumoniae Clinical Isolates in Sudanese Hospitals: Analytical Comparative Cross Sectional Study

Show simple item record

dc.contributor.author Hitham, Mohammed
dc.contributor.author Ahmed, Mohammed Ahmed
dc.contributor.author Saeed, Abdelgadir Saeed
dc.contributor.author Ahmed, Musa Abdalla
dc.contributor.author Nuraldeen, Mohammed Ali
dc.date.accessioned 2019-04-24T15:15:39Z
dc.date.available 2019-04-24T15:15:39Z
dc.date.issued 2018-11-30
dc.identifier.issn 2413-4910
dc.identifier.other DOI: 10.21276/sjmps.2018.4.11.6
dc.identifier.uri http://hdl.handle.net/123456789/613
dc.description Extended-spectrum – beta lactamases (ESBLs) are increasingly detected globally among Escherichia coli (E.Coli) and Klebsiella pneumoniae (K.pneumoniae). This study was designed to determine the prevalence and antibiogram of ESBLs produced by E.coli and K.pneumoniae clinical isolates obtained from various clinical specimens through different hospitals in Khartoum state -Sudan. An analytical comparative cross-sectional study was conducted. Identification of the isolates was done by using conventional biochemical methods ESBL screening, confirmatory according to CLSI guidelines. Statistical analysis was performed using the Statistical Package of Social Sciences (SPSS). Total of 368 isolates of Escherichia coli(n=216) and Klebsiella pneumonia (n=152) isolates were processed , Overall ESBL phenotype prevalence was 36.7 %, 40.1% and 34.2% of K. Pneumoniae and E. coli isolates respectively were confirmed to be ESBL phenotype. In this study, meropenem and imipenem were the most active antimicrobial agents against them. This study was indicated high prevalence of ESBL phenotype in Khartoum-state, with multidrug resistant trend, there is a need for longitudinal and nationwide surveillance as this help in tracking antibiotic resistant and regulating antibiotic policy. en_US
dc.description.abstract Extended-spectrum – beta lactamases (ESBLs) are increasingly detected globally among Escherichia coli (E.Coli) and Klebsiella pneumoniae (K.pneumoniae). This study was designed to determine the prevalence and antibiogram of ESBLs produced by E.coli and K.pneumoniae clinical isolates obtained from various clinical specimens through different hospitals in Khartoum state -Sudan. An analytical comparative cross-sectional study was conducted. Identification of the isolates was done by using conventional biochemical methods ESBL screening, confirmatory according to CLSI guidelines. Statistical analysis was performed using the Statistical Package of Social Sciences (SPSS). Total of 368 isolates of Escherichia coli(n=216) and Klebsiella pneumonia (n=152) isolates were processed , Overall ESBL phenotype prevalence was 36.7 %, 40.1% and 34.2% of K. Pneumoniae and E. coli isolates respectively were confirmed to be ESBL phenotype. In this study, meropenem and imipenem were the most active antimicrobial agents against them. This study was indicated high prevalence of ESBL phenotype in Khartoum-state, with multidrug resistant trend, there is a need for longitudinal and nationwide surveillance as this help in tracking antibiotic resistant and regulating antibiotic policy. en_US
dc.language.iso en_US en_US
dc.publisher Saudi Journal of Medical and Pharmaceutical Sciences en_US
dc.subject ESBL en_US
dc.subject MDR en_US
dc.subject Escherichia en_US
dc.subject coli en_US
dc.subject Klebsiella en_US
dc.subject Escherichia coli en_US
dc.title Extended-spectrum Beta-lactamase- Producing Escherichia coli and Klebsiella pneumoniae Clinical Isolates in Sudanese Hospitals: Analytical Comparative Cross Sectional Study en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account